We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · July 13, 2022

Validation of the Decipher Genomic Classifier in Patients Receiving Salvage Radiotherapy Without Hormone Therapy After Radical Prostatectomy

Annals of Oncology


Additional Info

Annals of Oncology
Validation of the Decipher genomic classifier in patients receiving salvage radiotherapy without hormone therapy after radical prostatectomy - an ancillary study of the SAKK 09/10 randomized clinical trial
Ann. Oncol 2022 May 28;[EPub Ahead of Print], AD Pra, P Ghadjar, S Hayoz, VYT Liu, DE Spratt, DJS Thompson, E Davicioni, HC Huang, X Zhao, Y Liu, C Schär, P Gut, L Plasswilm, T Hölscher, B Polat, G Hildebrandt, AC Müller, A Pollack, GN Thalmann, D Zwahlen, DM Aebersold

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading